Provectus Biopharmaceuticals, Inc. (PVCT):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82168FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Provectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 for atopic dermatitis, PV-10 for metastatic liver cancer, PV-10 for recurrent breast cancer and PV-10 mechanism of action. Provectus’s PH-10 is a product used in the treatment of psoriasis and atopic dermatitis. The company offers biotechnologies to augment vaccine production and detect viruses. It provides compassionate use programs of its therapeutics in St. Luke’s Hospital and Health Network, University of Louisville, Melanoma Institute Australia, Princess Alexandra Hospital, and Royal Adelaide Hospital. The company was formerly known as Provectus pharmaceuticals, Inc. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals, Inc. Key Recent Developments

Dec 17, 2013: Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
Nov 05, 2013: Provectus to Hold Special Meeting of Stockholders December 16, 2013, in Knoxville, Tennessee
Jun 05, 2013: Provectus Pharma Receives Patent Allowance From US Patent And Trademark Office
May 09, 2013: Provectus Pharma Reports Q1 2013 Results
Mar 14, 2013: Provectus Pharma Reports 2012 Results

This comprehensive SWOT profile of Provectus Biopharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Provectus Biopharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Provectus Biopharmaceuticals, Inc. – Key Information
Provectus Biopharmaceuticals, Inc. – Overview
Provectus Biopharmaceuticals, Inc. – Key Employees
Provectus Biopharmaceuticals, Inc. – Key Employee Biographies
Provectus Biopharmaceuticals, Inc. – Key Operational Heads
Provectus Biopharmaceuticals, Inc. – Major Products and Services
Provectus Biopharmaceuticals, Inc. – History
Provectus Biopharmaceuticals, Inc. – Company Statement
Provectus Biopharmaceuticals, Inc. – Locations And Subsidiaries
Provectus Biopharmaceuticals, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Provectus Biopharmaceuticals, Inc. – Business Description
Provectus Biopharmaceuticals, Inc. – Corporate Strategy
Provectus Biopharmaceuticals, Inc. – SWOT Analysis
SWOT Analysis – Overview
Provectus Biopharmaceuticals, Inc. – Strengths
Provectus Biopharmaceuticals, Inc. – Weaknesses
Provectus Biopharmaceuticals, Inc. – Opportunities
Provectus Biopharmaceuticals, Inc. – Threats
Provectus Biopharmaceuticals, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Provectus Biopharmaceuticals, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Provectus Biopharmaceuticals, Inc., Key Information
Provectus Biopharmaceuticals, Inc., Key Ratios
Provectus Biopharmaceuticals, Inc., Share Data
Provectus Biopharmaceuticals, Inc., Major Products and Services
Provectus Biopharmaceuticals, Inc., History
Provectus Biopharmaceuticals, Inc., Key Employees
Provectus Biopharmaceuticals, Inc., Key Employee Biographies
Provectus Biopharmaceuticals, Inc., Key Operational Heads
Provectus Biopharmaceuticals, Inc., Other Locations
Provectus Biopharmaceuticals, Inc., Subsidiaries
Provectus Biopharmaceuticals, Inc., Key Manufacturing facilities
Provectus Biopharmaceuticals, Inc., Key Competitors
Provectus Biopharmaceuticals, Inc., SWOT Analysis
Provectus Biopharmaceuticals, Inc., Ratios based on current share price
Provectus Biopharmaceuticals, Inc., Annual Ratios
Provectus Biopharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Provectus Biopharmaceuticals, Inc., Performance Chart
Provectus Biopharmaceuticals, Inc., Ratio Charts

★海外企業調査レポート[Provectus Biopharmaceuticals, Inc. (PVCT):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saab AB:戦略・SWOT・企業財務分析
    Saab AB - Strategy, SWOT and Corporate Finance Report Summary Saab AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • AUS Bio Limited:製品開発パイプライン動向2015
    AUS Bio Limited - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘AUS Bio Limited - Product Pipeline Review - 2015’, provides an overview of the AUS Bio Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic …
  • Tom Group Limited (2383):企業の財務及び戦略的SWOT分析
    Summary Tom Group Limited (Tom Group), a subsidiary of CK Hutchison Holdings Limited is a Chinese-language media conglomerate company that provides e-commerce and mobile internet services. The company operates though business segments such as E-Commerce, Mobile Internet, Publishing, Outdoor Media, T …
  • TriMedx, LLC:企業の戦略的SWOT分析
    TriMedx, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fabric Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalon …
  • Bio Techne Corp (TECH):企業のM&A・提携動向(医療機器分野)
    Summary Bio Techne Corp (Bio Techne), formerly Techne Corporation is a life science company that develops, produces and sells biotechnology products and hematology products. The company develops and manufactures hematology controls used in hospitals and clinical laboratories to check the accuracy of …
  • Sulzer Ltd:企業のM&A・提携・投資分析
    Sulzer Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sulzer Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Phillips 66 Company:企業の戦略・SWOT・財務分析
    SummaryPhillips 66 Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Luchthaven Schiphol N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Luchthaven Schiphol N.V. Merger …
  • Fenwal, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Fenwal, Inc. (Fenwal) is a pharmaceutical company that develops, manufactures and markets products to improve the safety and availability of blood. The company offers products for use in the practice of transfusion medicine, making life-saving blood therapies. Its products include amicus sep …
  • Atopix Therapeutics Limited(製薬・医療分野):企業M&A動向
    Summary Atopix Therapeutics Limited (Atopix Therapeutics) is a clinical-stage, biopharmaceutical company. It develops novel class of oral anti-allergic medicines. The company’s products are used in the therapeutic areas of atopic dermatitis, asthma and allergic rhinitis. Atopix Therapeutics pipeline …
  • Edan Instruments, Inc. (300206):企業の財務及び戦略的SWOT分析
    Summary Edan Instruments, Inc. (Edan Instruments) is an electronic medical equipment manufacturing company that develops, manufactures and distributes medical and laboratory diagnostic products. The company’s products include diagnostic ECG, patient monitoring devices, obstetrics and gynaecology mon …
  • Unic Technology Corporation (5452):企業財務及び戦略的SWOT分析
    Summary Unic Technology Corporation (UNIC) is a chemical company that dvelops, processes and markets bio materials, plastic materials, engineering plastic, auto parts and electronic materials. The company offers products such as bio material, plastic material, electronic material and rapid self heat …
  • National Power Corporation:企業の戦略的SWOT分析
    Summary National Power Corporation (NPC) is a Philippines-based government-owned company. The company is engaged in the development, utilization and conservation of water resources for all beneficial uses, including power generation. It is also engaged in development of power from all renewable sour …
  • Janssen Research & Development, LLC(製薬・医療分野):企業M&A動向
    Summary Janssen Research & Development, LLC (Janssen) is a pharmaceutical company. The company discovers and develops transformational medical solutions that treat, cure and prevent disease. Janssen offers treatment in therapeutic areas such as cardiovascular and metabolism; immunology; infectious d …
  • Nectar Lifesciences Ltd. (NECLIFE):企業の財務及び戦略的SWOT分析
    Summary Nectar Lifesciences Ltd (NecLife) is a research driven pharmaceutical company that manufactures Active pharmaceutical ingredients (APIs). It offers contract research and manufacturing services such as process development and optimization, process scale up and validation, multi kilo pilot pla …
  • PSR Group BV-製薬・医療分野:企業M&A・提携分析
    Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company’s PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provi …
  • Bancolombia S.A.:企業の戦略・SWOT・財務分析
    SummaryBancolombia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Warburg Pincus LLC:戦略・SWOT・企業財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Thor Mining Plc (THR):企業の財務及び戦略的SWOT分析
    Summary Thor Mining Plc (Thor) is a mineral exploration company that explores and develops gold, tungsten and molybdenum properties. The company’s projects include Molyhil Tungsten and Molybdenum, Spring Hill Gold, Dundas Gold project, and Pilot Mountain Tungsten Project. Its Molyhil Tungsten and Mo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆